Literature DB >> 35593638

Update From the Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries: The SAFE-PAD Study.

Eric A Secemsky1,2,3, Yang Song1, Marc Schermerhorn2,4, Robert W Yeh1,2,3.   

Abstract

Entities:  

Keywords:  Medicare; angioplasty; drug-eluting stent; mortality; paclitaxel

Mesh：

Substances：

Year:  2022        PMID： 35593638      PMCID： PMC9473309          DOI： 10.1161/CIRCINTERVENTIONS.122.012074

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   7.514


× No keyword cloud information.
  5 in total

1.  Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease.

Authors:  Joakim Nordanstig; Stefan James; Manne Andersson; Mattias Andersson; Peter Danielsson; Peter Gillgren; Martin Delle; Jan Engström; Torbjörn Fransson; Maher Hamoud; Anna Hilbertson; Patrik Johansson; Lars Karlsson; Björn Kragsterman; Hans Lindgren; Karin Ludwigs; Stefan Mellander; Niklas Nyman; Henrik Renlund; Birgitta Sigvant; Per Skoog; Joachim Starck; Gustaf Tegler; Asko Toivola; Maria Truedson; Carl-Magnus Wahlgren; Jonas Wallinder; Andreas Öjersjö; Mårten Falkenberg
Journal:  N Engl J Med       Date:  2020-12-09       Impact factor: 91.245

2.  Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.

Authors:  Connie N Hess; Manesh R Patel; Rupert M Bauersachs; Sonia S Anand; E Sebastian Debus; Mark R Nehler; Fabrizio Fanelli; Robert W Yeh; Eric A Secemsky; Joshua A Beckman; Laura Mauri; Nicholas Govsyeyev; Warren H Capell; Taylor Brackin; Scott D Berkowitz; Eva Muehlhofer; Lloyd P Haskell; William R Hiatt; Marc P Bonaca
Journal:  J Am Coll Cardiol       Date:  2021-11-02       Impact factor: 24.094

3.  Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries: The SAFE-PAD Study.

Authors:  Eric A Secemsky; Changyu Shen; Marc Schermerhorn; Robert W Yeh
Journal:  JAMA Intern Med       Date:  2021-08-01       Impact factor: 21.873

4.  Rationale and Design of the SAFE-PAD Study.

Authors:  Eric A Secemsky; Aishwarya Raja; Changyu Shen; Linda R Valsdottir; Marc Schermerhorn; Robert W Yeh
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-01-13

5.  Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Konstantinos Katsanos; Stavros Spiliopoulos; Panagiotis Kitrou; Miltiadis Krokidis; Dimitrios Karnabatidis
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.